Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Biomarkers / CD177

CD177

Basics

Aliases:
This biomarker is also known as:
  • Human neutrophil alloantigen 2a,
  • PRV-1,
  • HNA-2a,
  • Polycythemia rubra vera protein 1,
  • HNA2A,
  • NB1,
  • CD177 antigen,
  • polycythemia rubra vera protein 1,
  • NB1 glycoprotein,
  • human neutrophil alloantigen 2a,
  • NB1 GP,
  • CD177 molecule,
  • polycythemia rubra vera 1,
  • PRV1,
  • cell surface receptor,

Description…

CD177 molecule

Attributes

QA State: Under Review
Type: Gene
Short Name:
HGNC Name: CD177

Datasets

There are no datasets associated with this biomarker.

Organs

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Publications

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Resources

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Biomuta

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.